If you had to short one asset right now, what would it be? #marketanalysis #investing #trading
1 extracted signal · 0 resolved · 1 still active
Milk RoadIndependent analyst profile- Source published
- 18 Sept 2026, 18:30 UTC
- Recorded by Tahlil Plus
- 18 Sept 2026, 21:33 UTC

AI-generated source summary
The market analysis focuses on potential shorting opportunities. The US Dollar Index (DXY) is seen as bearish, with a target of 100.0 from a current price of 103.5, invalidating below 104.0. Bitcoin (BTCUSDT) is predicted to be bullish, aiming for 75,000.0 from its current price of 68,000.0, with a failure bound at 66,000.0. Cardano (ADAUSDT) is viewed as bearish, targeting 0.35 from 0.45, and will fail if it moves above 0.50. Robinhood (HOOD) is also a bearish candidate, with a target of 10.0 from its current 15.0, and a failure point at 17.0. Moderna (MRNA) is considered overvalued and a potential short, targeting 70.0 from 100.0, with a stop-loss at 110.0. Finally, Gold (XAUUSD) is suggested for a short position, aiming for 1900.0 from 2000.0, with a break-even point set at 2050.0. The rationale for shorting oil is based on geopolitical factors and potential pipeline repairs that could increase supply.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Milk Road
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
